Abstract:Objective To investigate the feasibility and accuracy of quantifying liver iron concentration (LIC) in patients with thalassemia (TM) using 1.5T and 3T T 2 * MRI. Methods 1.5T MRI T 2 * values were measured in 391 TM patients from three medical centers: the T 2 * values of the test group were combined with the LIC (LIC F ) provided by FerriScan to construct the curve equation. In addition, the liver 3T MRI liver T 2 * data of 55 TM patients were measured as the 3T group: the curve equation of 3T T 2 * value and LIC F was constructed. Results Based on the test group LIC F (0.6–43 mg/g dw) and the corresponding 1.5T T 2 * value, the equation was LIC F = 37.393 T 2 * ∧ (−1.22) (R 2 = 0.971; P < 0.001). There was no significant difference between LIC e − 1.5T and LIC F in each validation group ( Z = −1.269, −0.977, −1.197; P = 0.204, 0.328, 0.231). There was significant consistency (Kendall's W = 0.991, 0.985, 0.980; all P < 0.001) and high correlation (r s = 0.983, 0.971, 0.960; all P < 0.001) between the two methods. There was no significant difference between the clinical grading results of LIC e − 1.5T and LIC F in each validation group (χ 2 = 3.0, 4.0, 2.0; P = 0.083, 0.135, 0.157), and there was significant consistency between the clinical grading results (Kappa's K = 0.943, 0.891, 0.953; P < 0.001). There was no statistical correlation between the LIC F (≥14 mg/g dw) and the 3T T 2 * value of severe iron overload ( P = 0.085). The LIC F (2–14 mg/g dw) in mild and moderate iron overload was significantly correlated with the corresponding T 2 * value (r s = −0.940; P < 0.001). The curve equation constructed from LIC F and corresponding 3T T 2 * values in this range is LIC F = 18.463T 2 * ∧ (−1.142) (R 2 = 0.889; P < 0.001). There was no significant difference between LIC F and LIC e − 3T in the mild to moderate range (Z = −0.523; P = 0.601), and there was a significant correlation (r s = 0.940; P < 0.001) and significant consistency (Kendall's W = 0.970; P = 0.008) between them. LIC e − 3T had high diagnostic efficiency in the diagnosis of severe, moderate, and mild liver iron overload (specificity = 1.000, 0.909; sensitivity = 0.972, 1.000). Conclusion The liver iron concentration can be accurately quantified based on the 1.5T T 2 * value of the liver and the specific LIC-T 2 * curve equation. 3T T 2 * technology can accurately quantify mild-to-moderate LIC, but it is not recommended to use 3T T 2 * technology to quantify higher iron concentrations.

Myocardial T2 quantitation in patients with iron overload at 3 Tesla.

Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment

Free-breathing, Non-Ecg, Simultaneous Myocardial T1 , T2 , T2 *, and Fat-Fraction Mapping with Motion-Resolved Cardiovascular MR Multitasking.

Cardiac T2 * mapping: Techniques and clinical applications

Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model

Early detection of myocardial iron overload in patients with β-thalassemia major using cardiac magnetic resonance T1 mapping

Quantification of Cardiac Iron Overload at 3 T MRI in a Rabbit Model Utilizing ME–GRE T2* Sequence

A multicenter study on the quantification of liver iron concentration in thalassemia patients by means of the MRI T2* technique

Quantification of Myocardial Extracellular Volume Fraction with Cardiac MR Imaging in Thalassemia Major

Cardiac Iron Overload by MRI in Children With B-Thalassemia Major and its Correlation With Cardiac Function by Echocardiography

Myocardial T2* Imaging at 3T and 1.5T: A Pilot Study with Phantom and Normal Myocardium

The relationship of myocardial and liver T2* values with cardiac function and laboratory findings in transfusion-dependent thalassemia major patients: A retrospective cardiac MRI study

Myocardial Iron Loading Assessment by Automatic Left Ventricle Segmentation with Morphological Operations and Geodesic Active Contour on T2* images

The Evaluation of Renal Iron Deposition With a 3 Tesla MRI Device in Beta-Thalassemia Major Patients

Cardiac Iron Measurement and Iron Chelation Therapy in Patients with Β Thalassaemia Major: Experience from Taiwan.

The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia

MRI assessment of excess cardiac iron in thalassemia major: When to initiate?

Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia

Myocardial deformation in patients with Beta-thalassemia major: a speckle tracking echocardiographic study.

Assessment of the relationship between fragmented QRS and cardiac iron overload in patients with beta-thalassemia major

Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T